Increased serum leptin level in overweight patients with colon carcinoma: A cross-sectional and prospective study

Leptin is associated with carcinogenesis and progression of various cancers. However, the changes of the serum leptin level in Chinese overweight patients with colon carcinoma and its association with response to treatment in these patients have rarely been investigated. A total of 63 Chinese overwe...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Molecular and clinical oncology Ročník 6; číslo 1; s. 75 - 78
Hlavní autori: Wang, Di, Gao, Lichen, Gong, Kuiyu, Chai, Qin, Wang, Guihua
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England D.A. Spandidos 01.01.2017
Spandidos Publications
Spandidos Publications UK Ltd
Predmet:
ISSN:2049-9450, 2049-9469
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Leptin is associated with carcinogenesis and progression of various cancers. However, the changes of the serum leptin level in Chinese overweight patients with colon carcinoma and its association with response to treatment in these patients have rarely been investigated. A total of 63 Chinese overweight patients with colon cancer and 40 body mass index-matched control subjects were recruited in the present study. The serum leptin levels of colon cancer patients prior to and 21 days after colectomy, as well as those of healthy controls, were measured and compared. In addition, the focal expression of phosphorylated Akt, mammalian target of rapamycin and 70S6 Kinase (p-Akt, p-mTOR and P-70S6 Kinase) and leptin were determined in the resected specimens and the correlation between serum leptin levels and the focally expressed markers were investigated. The serum leptin levels of colon cancer patients were significantly higher compared with those of the controls (22.67±12.56 vs. 12.68±7.8 ng/ml, respectively; P<0.05). Moreover, the leptin levels decreased after the operation when compared to the preoperative levels (18.67±8.54 vs. 22.67±12.56 ng/ml, respectively; P<0.05). In addition, there was a significant correlation between the serum leptin levels and the focal expression of p-Akt, p-mTOR, P-70S6 Kinase and leptin (P<0.05). In conclusion, the leptin levels were elevated in Chinese overweight patients with colon cance these levels decreased following colectomy, indicating that leptin may be associated with colon carcinogenesis. Thus, serum leptin level may be used for early diagnosis and for monitoring the response to treatment of colon carcinoma in overweight Chinese patients.
AbstractList Leptin is associated with carcinogenesis and progression of various cancers. However, the changes of the serum leptin level in Chinese overweight patients with colon carcinoma and its association with response to treatment in these patients have rarely been investigated. A total of 63 Chinese overweight patients with colon cancer and 40 body mass index-matched control subjects were recruited in the present study. The serum leptin levels of colon cancer patients prior to and 21 days after colectomy, as well as those of healthy controls, were measured and compared. In addition, the focal expression of phosphorylated Akt, mammalian target of rapamycin and 70S6 Kinase (p-Akt, p-mTOR and P-70S6 Kinase) and leptin were determined in the resected specimens and the correlation between serum leptin levels and the focally expressed markers were investigated. The serum leptin levels of colon cancer patients were significantly higher compared with those of the controls (22.67 ± 12.56 vs. 12.68 ± 7.8 ng/ml, respectively; P<0.05). Moreover, the leptin levels decreased after the operation when compared to the preoperative levels (18.67 ± 8.54 vs. 22.67 ± 12.56 ng/ml, respectively; P<0.05). In addition, there was a significant correlation between the serum leptin levels and the focal expression of p-Akt, p-mTOR, P-70S6 Kinase and leptin (P<0.05). In conclusion, the leptin levels were elevated in Chinese overweight patients with colon cance these levels decreased following colectomy, indicating that leptin may be associated with colon carcinogenesis. Thus, serum leptin level may be used for early diagnosis and for monitoring the response to treatment of colon carcinoma in overweight Chinese patients. Key words: serum leptin, overweight, colon carcinoma, body mass index, Chinese
Leptin is associated with carcinogenesis and progression of various cancers. However, the changes of the serum leptin level in Chinese overweight patients with colon carcinoma and its association with response to treatment in these patients have rarely been investigated. A total of 63 Chinese overweight patients with colon cancer and 40 body mass index-matched control subjects were recruited in the present study. The serum leptin levels of colon cancer patients prior to and 21 days after colectomy, as well as those of healthy controls, were measured and compared. In addition, the focal expression of phosphorylated Akt, mammalian target of rapamycin and 70S6 Kinase (p-Akt, p-mTOR and P-70S6 Kinase) and leptin were determined in the resected specimens and the correlation between serum leptin levels and the focally expressed markers were investigated. The serum leptin levels of colon cancer patients were significantly higher compared with those of the controls (22.67±12.56 vs. 12.68±7.8 ng/ml, respectively; P<0.05). Moreover, the leptin levels decreased after the operation when compared to the preoperative levels (18.67±8.54 vs. 22.67±12.56 ng/ml, respectively; P<0.05). In addition, there was a significant correlation between the serum leptin levels and the focal expression of p-Akt, p-mTOR, P-70S6 Kinase and leptin (P<0.05). In conclusion, the leptin levels were elevated in Chinese overweight patients with colon cance these levels decreased following colectomy, indicating that leptin may be associated with colon carcinogenesis. Thus, serum leptin level may be used for early diagnosis and for monitoring the response to treatment of colon carcinoma in overweight Chinese patients.
Leptin is associated with carcinogenesis and progression of various cancers. However, the changes of the serum leptin level in Chinese overweight patients with colon carcinoma and its association with response to treatment in these patients have rarely been investigated. A total of 63 Chinese overweight patients with colon cancer and 40 body mass index-matched control subjects were recruited in the present study. The serum leptin levels of colon cancer patients prior to and 21 days after colectomy, as well as those of healthy controls, were measured and compared. In addition, the focal expression of phosphorylated Akt, mammalian target of rapamycin and 70S6 Kinase (p-Akt, p-mTOR and P-70S6 Kinase) and leptin were determined in the resected specimens and the correlation between serum leptin levels and the focally expressed markers were investigated. The serum leptin levels of colon cancer patients were significantly higher compared with those of the controls (22.67±12.56 vs. 12.68±7.8 ng/ml, respectively; P<0.05). Moreover, the leptin levels decreased after the operation when compared to the preoperative levels (18.67±8.54 vs. 22.67±12.56 ng/ml, respectively; P<0.05). In addition, there was a significant correlation between the serum leptin levels and the focal expression of p-Akt, p-mTOR, P-70S6 Kinase and leptin (P<0.05). In conclusion, the leptin levels were elevated in Chinese overweight patients with colon cance these levels decreased following colectomy, indicating that leptin may be associated with colon carcinogenesis. Thus, serum leptin level may be used for early diagnosis and for monitoring the response to treatment of colon carcinoma in overweight Chinese patients.Leptin is associated with carcinogenesis and progression of various cancers. However, the changes of the serum leptin level in Chinese overweight patients with colon carcinoma and its association with response to treatment in these patients have rarely been investigated. A total of 63 Chinese overweight patients with colon cancer and 40 body mass index-matched control subjects were recruited in the present study. The serum leptin levels of colon cancer patients prior to and 21 days after colectomy, as well as those of healthy controls, were measured and compared. In addition, the focal expression of phosphorylated Akt, mammalian target of rapamycin and 70S6 Kinase (p-Akt, p-mTOR and P-70S6 Kinase) and leptin were determined in the resected specimens and the correlation between serum leptin levels and the focally expressed markers were investigated. The serum leptin levels of colon cancer patients were significantly higher compared with those of the controls (22.67±12.56 vs. 12.68±7.8 ng/ml, respectively; P<0.05). Moreover, the leptin levels decreased after the operation when compared to the preoperative levels (18.67±8.54 vs. 22.67±12.56 ng/ml, respectively; P<0.05). In addition, there was a significant correlation between the serum leptin levels and the focal expression of p-Akt, p-mTOR, P-70S6 Kinase and leptin (P<0.05). In conclusion, the leptin levels were elevated in Chinese overweight patients with colon cance these levels decreased following colectomy, indicating that leptin may be associated with colon carcinogenesis. Thus, serum leptin level may be used for early diagnosis and for monitoring the response to treatment of colon carcinoma in overweight Chinese patients.
Leptin is associated with carcinogenesis and progression of various cancers. However, the changes of the serum leptin level in Chinese overweight patients with colon carcinoma and its association with response to treatment in these patients have rarely been investigated. A total of 63 Chinese overweight patients with colon cancer and 40 body mass index-matched control subjects were recruited in the present study. The serum leptin levels of colon cancer patients prior to and 21 days after colectomy, as well as those of healthy controls, were measured and compared. In addition, the focal expression of phosphorylated Akt, mammalian target of rapamycin and 70S6 Kinase (p-Akt, p-mTOR and P-70S6 Kinase) and leptin were determined in the resected specimens and the correlation between serum leptin levels and the focally expressed markers were investigated. The serum leptin levels of colon cancer patients were significantly higher compared with those of the controls (22.67 ± 12.56 vs. 12.68 ± 7.8 ng/ml, respectively; P<0.05). Moreover, the leptin levels decreased after the operation when compared to the preoperative levels (18.67 ± 8.54 vs. 22.67 ± 12.56 ng/ml, respectively; P<0.05). In addition, there was a significant correlation between the serum leptin levels and the focal expression of p-Akt, p-mTOR, P-70S6 Kinase and leptin (P<0.05). In conclusion, the leptin levels were elevated in Chinese overweight patients with colon cance these levels decreased following colectomy, indicating that leptin may be associated with colon carcinogenesis. Thus, serum leptin level may be used for early diagnosis and for monitoring the response to treatment of colon carcinoma in overweight Chinese patients.
Audience Academic
Author Wang, Guihua
Wang, Di
Gao, Lichen
Gong, Kuiyu
Chai, Qin
AuthorAffiliation 1 Department of Oncology, Changsha Central Hospital, Changsha, Hunan 410004, P.R. China
2 Department of Pharmacy, Changsha Central Hospital, Changsha, Hunan 410004, P.R. China
AuthorAffiliation_xml – name: 1 Department of Oncology, Changsha Central Hospital, Changsha, Hunan 410004, P.R. China
– name: 2 Department of Pharmacy, Changsha Central Hospital, Changsha, Hunan 410004, P.R. China
Author_xml – sequence: 1
  givenname: Di
  surname: Wang
  fullname: Wang, Di
  organization: 1Department of Oncology, Changsha Central Hospital, Changsha, Hunan 410004, P.R. China
– sequence: 2
  givenname: Lichen
  surname: Gao
  fullname: Gao, Lichen
  organization: 2Department of Pharmacy, Changsha Central Hospital, Changsha, Hunan 410004, P.R. China
– sequence: 3
  givenname: Kuiyu
  surname: Gong
  fullname: Gong, Kuiyu
  organization: 1Department of Oncology, Changsha Central Hospital, Changsha, Hunan 410004, P.R. China
– sequence: 4
  givenname: Qin
  surname: Chai
  fullname: Chai, Qin
  organization: 1Department of Oncology, Changsha Central Hospital, Changsha, Hunan 410004, P.R. China
– sequence: 5
  givenname: Guihua
  surname: Wang
  fullname: Wang, Guihua
  organization: 1Department of Oncology, Changsha Central Hospital, Changsha, Hunan 410004, P.R. China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28123733$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1v3CAQhq0qVZOmOfZaIVWVevEWMMamh0irVT8ipcqlPSMWD7tENjiAN8q_L84m2yZq4QAannkHeOd1ceS8g6J4S_CiagX9NGi_oJjwBcFt86I4oZiJUjAujg77Gh8XZzFe4zxEg2ktXhXHtCW0aqrqpLi5cDqAitChCGEaUA9jsi4vO-hR3vgdhFuwm21Co0oWXIro1qYt0r73DmkVtHV-UJ_REungYywj6GS9Uz1SrkNjjo1zZAcopqm7e1O8NKqPcPawnha_vn75ufpeXl59u1gtL0vNGE1lJTjpdN1AC6ZrRNdy0Lymal0TRtu6xYobtWZdvdacGq5Ma7SuNK4NM1RpUZ0W53vdcVoP0Ol886B6OQY7qHAnvbLy6YmzW7nxO1lTxlpOs8DHB4HgbyaISQ42auh75cBPUZIM0ZZxwjL6_hl67aeQvyBToiK8aQghf6iN6kFaZ3yuq2dRuWSN4LluPZdd_IPKs4PB6uy_sTn-JOHd3w89vPDR5AxUe-DenwBGapvU7FFWtr0kWM7dJHM3ybmb5NxNOat8lvUo_D_-w56PY_bddj4eEn6srkqc5z33G2em2TQ
CitedBy_id crossref_primary_10_1016_j_bbadis_2021_166281
crossref_primary_10_3390_biom11060913
crossref_primary_10_3390_ijms25189820
crossref_primary_10_1017_S0007114523002283
crossref_primary_10_1371_journal_pone_0206519
crossref_primary_10_1007_s00535_019_01600_x
crossref_primary_10_3390_ijerph20064951
crossref_primary_10_3892_ijo_2019_4807
Cites_doi 10.1111/j.1349-7006.2010.01518.x
10.1007/s12038-011-9172-4
10.1038/nm1195-1155
10.1016/S1470-2045(05)70422-8
10.1158/1055-9965.EPI-07-0467
10.1056/NEJM199602013340503
10.1007/s00384-008-0605-y
10.1002/ijc.11668
10.1038/nrc1408
10.1002/jcp.20472
ContentType Journal Article
Copyright Copyright © 2016, Spandidos Publications
COPYRIGHT 2017 Spandidos Publications
Copyright Spandidos Publications UK Ltd. 2017
Copyright © 2016, Spandidos Publications 2016
Copyright_xml – notice: Copyright © 2016, Spandidos Publications
– notice: COPYRIGHT 2017 Spandidos Publications
– notice: Copyright Spandidos Publications UK Ltd. 2017
– notice: Copyright © 2016, Spandidos Publications 2016
DBID HUR
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3892/mco.2016.1087
DatabaseName Spandidos
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
British Nursing Index with Full Text
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
ProQuest One Health & Nursing
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central (New)
ProQuest One Academic
ProQuest Central (Alumni)
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList

PubMed
MEDLINE - Academic

ProQuest One Academic Middle East (New)

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 2049-9469
EndPage 78
ExternalDocumentID PMC5244862
A479624452
28123733
10_3892_mco_2016_1087
MCO-0-0-1087
Genre Journal Article
GeographicLocations China
United States--US
GeographicLocations_xml – name: China
– name: United States--US
GroupedDBID 0R~
53G
7X7
8FI
8FJ
ABDBF
ABUWG
ACGFS
ACUHS
ADBBV
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AN0
BENPR
BNQBC
BPHCQ
BVXVI
C45
CCPQU
EBD
EBS
EJD
ESX
FYUFA
H13
HMCUK
HUR
HZ~
IAO
IHR
IPNFZ
ITC
O9-
OK1
OVD
PHGZM
PHGZT
PPXIY
PQQKQ
PROAC
PUEGO
RIG
RPM
TEORI
UKHRP
AAYXX
AFFHD
CITATION
ALIPV
NPM
3V.
7XB
8FK
K9.
PJZUB
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c442t-3961dc57e8efd79d86ec652ab51428580a6fab4d5bc62f6af8fcc3c05f4f2ac93
IEDL.DBID 7X7
ISICitedReferencesCount 11
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000453170400013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2049-9450
IngestDate Tue Nov 04 02:01:48 EST 2025
Thu Sep 04 17:52:33 EDT 2025
Tue Oct 07 07:10:54 EDT 2025
Tue Nov 11 10:14:28 EST 2025
Tue Nov 04 17:42:41 EST 2025
Thu Apr 03 07:02:02 EDT 2025
Sat Nov 29 03:27:02 EST 2025
Tue Nov 18 21:19:49 EST 2025
Tue Sep 30 17:19:38 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Keywords colon carcinoma
Chinese
serum leptin
overweight
body mass index
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c442t-3961dc57e8efd79d86ec652ab51428580a6fab4d5bc62f6af8fcc3c05f4f2ac93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Contributed equally
OpenAccessLink http://www.spandidos-publications.com/10.3892/mco.2016.1087/download
PMID 28123733
PQID 1931677111
PQPubID 2044956
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5244862
proquest_miscellaneous_1862284614
proquest_journals_1931677111
gale_infotracmisc_A479624452
gale_infotracacademiconefile_A479624452
pubmed_primary_28123733
crossref_citationtrail_10_3892_mco_2016_1087
crossref_primary_10_3892_mco_2016_1087
spandidos_primary_MCO-0-0-1087
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Athens
PublicationTitle Molecular and clinical oncology
PublicationTitleAlternate Mol Clin Oncol
PublicationYear 2017
Publisher D.A. Spandidos
Spandidos Publications
Spandidos Publications UK Ltd
Publisher_xml – name: D.A. Spandidos
– name: Spandidos Publications
– name: Spandidos Publications UK Ltd
References Considine, Sinha, Heiman, Kriauciunas, Stephens, Nyce, Ohannesian, Marco, McKee, Bauer (b1-mco-0-0-1087) 1996; 334
Chia, Newcomb, Lampe, White, Mandelson, McTiernan, Potter (b5-mco-0-0-1087) 2007; 16
Nakajima, Yamada, Hamano, Furuta, Matsuda, Fujita, Kato, Hamaguchi, Shimada (b8-mco-0-0-1087) 2010; 101
Calle, Kaaks (b10-mco-0-0-1087) 2004; 4
Wang, Chen, Guo, Chen, Duan, Wei, Xu, Wang, Zhong (b11-mco-0-0-1087) 2011; 12
Garofalo, Surmacz (b4-mco-0-0-1087) 2006; 207
Stattin, Lukanova, Biessy, Söderberg, Palmqvist, Kaaks, Olsson, Jellum (b6-mco-0-0-1087) 2004; 109
Baratta (b3-mco-0-0-1087) 2002; 8
Kumor, Daniel, Pietruczuk, Malecka-Panas (b7-mco-0-0-1087) 2009; 24
Maffei, Halaas, Ravussin, Pratley, Lee, Zhang, Fei, Kim, Lallone, Ranganathan (b2-mco-0-0-1087) 1995; 1
Sung, Lau, Goh, Leung (b9-mco-0-0-1087) 2005; 6
Wang, Chen, Chen, Duan, Xu, Wei, Wang, Zhong (b12-mco-0-0-1087) 2012; 37
Maffei (key20180107152312_b2-mco-0-0-1087) 1995; 1
Stattin (key20180107152312_b6-mco-0-0-1087) 2004; 109
Kumor (key20180107152312_b7-mco-0-0-1087) 2009; 24
Sung (key20180107152312_b9-mco-0-0-1087) 2005; 6
Considine (key20180107152312_b1-mco-0-0-1087) 1996; 334
Calle (key20180107152312_b10-mco-0-0-1087) 2004; 4
Wang (key20180107152312_b11-mco-0-0-1087) 2011; 12
Garofalo (key20180107152312_b4-mco-0-0-1087) 2006; 207
Baratta (key20180107152312_b3-mco-0-0-1087) 2002; 8
Chia (key20180107152312_b5-mco-0-0-1087) 2007; 16
Nakajima (key20180107152312_b8-mco-0-0-1087) 2010; 101
Wang (key20180107152312_b12-mco-0-0-1087) 2012; 37
20331631 - Cancer Sci. 2010 May;101(5):1286-91
16110483 - J Cell Physiol. 2006 Apr;207(1):12-22
12503048 - Med Sci Monit. 2002 Dec;8(12):RA282-92
14735482 - Int J Cancer. 2004 Mar;109(1):149-52
7584987 - Nat Med. 1995 Nov;1(11):1155-61
18086776 - Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2697-703
16257795 - Lancet Oncol. 2005 Nov;6(11):871-6
15286738 - Nat Rev Cancer. 2004 Aug;4(8):579-91
22357207 - J Biosci. 2012 Mar;37(1):91-101
18979105 - Int J Colorectal Dis. 2009 Mar;24(3):275-81
22320958 - Asian Pac J Cancer Prev. 2011;12(10):2581-4
8532024 - N Engl J Med. 1996 Feb 1;334(5):292-5
References_xml – volume: 12
  start-page: 2581
  year: 2011
  end-page: 2584
  ident: b11-mco-0-0-1087
  article-title: Clinical significance of mTOR and p-mTOR protein expression in human colorectal carcinomas
  publication-title: Asian Pac J Cancer Prev
– volume: 101
  start-page: 1286
  year: 2010
  end-page: 1291
  ident: b8-mco-0-0-1087
  article-title: Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma and resistin and visfatin for colorectal cancer
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2010.01518.x
– volume: 37
  start-page: 91
  year: 2012
  end-page: 101
  ident: b12-mco-0-0-1087
  article-title: Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway
  publication-title: J Biosci
  doi: 10.1007/s12038-011-9172-4
– volume: 1
  start-page: 1155
  year: 1995
  end-page: 1161
  ident: b2-mco-0-0-1087
  article-title: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
  publication-title: Nat Med
  doi: 10.1038/nm1195-1155
– volume: 6
  start-page: 871
  year: 2005
  end-page: 876
  ident: b9-mco-0-0-1087
  article-title: Asia Pacific Working Group on Colorectal Cancer: Increasing incidence of colorectal cancer in Asia: Implications for screening
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(05)70422-8
– volume: 16
  start-page: 2697
  year: 2007
  end-page: 2703
  ident: b5-mco-0-0-1087
  article-title: Leptin concentrations, leptin receptor polymorphisms and colorectal adenoma risk
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-07-0467
– volume: 334
  start-page: 292
  year: 1996
  end-page: 295
  ident: b1-mco-0-0-1087
  article-title: Serum immunoreactive-leptin concentrations in normal-weight and obese humans
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199602013340503
– volume: 24
  start-page: 275
  year: 2009
  end-page: 281
  ident: b7-mco-0-0-1087
  article-title: Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-008-0605-y
– volume: 109
  start-page: 149
  year: 2004
  end-page: 152
  ident: b6-mco-0-0-1087
  article-title: Obesity and colon cancer: Does leptin provide a link?
  publication-title: Int J Cancer
  doi: 10.1002/ijc.11668
– volume: 4
  start-page: 579
  year: 2004
  end-page: 591
  ident: b10-mco-0-0-1087
  article-title: Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1408
– volume: 8
  start-page: RA282
  year: 2002
  end-page: RA292
  ident: b3-mco-0-0-1087
  article-title: Leptin-from a signal of adiposity to a hormonal mediator in peripheral tissues
  publication-title: Med Sci Moni
– volume: 207
  start-page: 12
  year: 2006
  end-page: 22
  ident: b4-mco-0-0-1087
  article-title: Leptin and cancer
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.20472
– volume: 8
  start-page: RA282
  year: 2002
  ident: key20180107152312_b3-mco-0-0-1087
  article-title: Leptin-from a signal of adiposity to a hormonal mediator in peripheral tissues
  publication-title: Med Sci Moni
– volume: 12
  start-page: 2581
  year: 2011
  ident: key20180107152312_b11-mco-0-0-1087
  article-title: Clinical significance of mTOR and p-mTOR protein expression in human colorectal carcinomas
  publication-title: Asian Pac J Cancer Prev
– volume: 16
  start-page: 2697
  year: 2007
  ident: key20180107152312_b5-mco-0-0-1087
  article-title: Leptin concentrations, leptin receptor polymorphisms and colorectal adenoma risk
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-07-0467
– volume: 334
  start-page: 292
  year: 1996
  ident: key20180107152312_b1-mco-0-0-1087
  article-title: Serum immunoreactive-leptin concentrations in normal-weight and obese humans
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199602013340503
– volume: 6
  start-page: 871
  year: 2005
  ident: key20180107152312_b9-mco-0-0-1087
  article-title: Asia Pacific Working Group on Colorectal Cancer: Increasing incidence of colorectal cancer in Asia: Implications for screening
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(05)70422-8
– volume: 4
  start-page: 579
  year: 2004
  ident: key20180107152312_b10-mco-0-0-1087
  article-title: Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1408
– volume: 109
  start-page: 149
  year: 2004
  ident: key20180107152312_b6-mco-0-0-1087
  article-title: Obesity and colon cancer: Does leptin provide a link?
  publication-title: Int J Cancer
  doi: 10.1002/ijc.11668
– volume: 37
  start-page: 91
  year: 2012
  ident: key20180107152312_b12-mco-0-0-1087
  article-title: Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/Akt/mTOR signalling pathway
  publication-title: J Biosci
  doi: 10.1007/s12038-011-9172-4
– volume: 207
  start-page: 12
  year: 2006
  ident: key20180107152312_b4-mco-0-0-1087
  article-title: Leptin and cancer
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.20472
– volume: 24
  start-page: 275
  year: 2009
  ident: key20180107152312_b7-mco-0-0-1087
  article-title: Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients
  publication-title: Int J Colorectal Dis
  doi: 10.1007/s00384-008-0605-y
– volume: 1
  start-page: 1155
  year: 1995
  ident: key20180107152312_b2-mco-0-0-1087
  article-title: Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
  publication-title: Nat Med
  doi: 10.1038/nm1195-1155
– volume: 101
  start-page: 1286
  year: 2010
  ident: key20180107152312_b8-mco-0-0-1087
  article-title: Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma and resistin and visfatin for colorectal cancer
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2010.01518.x
– reference: 16110483 - J Cell Physiol. 2006 Apr;207(1):12-22
– reference: 14735482 - Int J Cancer. 2004 Mar;109(1):149-52
– reference: 22320958 - Asian Pac J Cancer Prev. 2011;12(10):2581-4
– reference: 16257795 - Lancet Oncol. 2005 Nov;6(11):871-6
– reference: 15286738 - Nat Rev Cancer. 2004 Aug;4(8):579-91
– reference: 20331631 - Cancer Sci. 2010 May;101(5):1286-91
– reference: 8532024 - N Engl J Med. 1996 Feb 1;334(5):292-5
– reference: 7584987 - Nat Med. 1995 Nov;1(11):1155-61
– reference: 12503048 - Med Sci Monit. 2002 Dec;8(12):RA282-92
– reference: 18979105 - Int J Colorectal Dis. 2009 Mar;24(3):275-81
– reference: 18086776 - Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2697-703
– reference: 22357207 - J Biosci. 2012 Mar;37(1):91-101
SSID ssj0000970259
ssib053393498
Score 2.0513353
Snippet Leptin is associated with carcinogenesis and progression of various cancers. However, the changes of the serum leptin level in Chinese overweight patients with...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
spandidos
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 75
SubjectTerms Adipocytes
Apoptosis
Biotechnology
Body mass index
Care and treatment
Chinese
Colon cancer
colon carcinoma
Colonoscopy
Colorectal cancer
Colorectal surgery
Development and progression
Drug metabolism
Genetic aspects
Health aspects
Leptin
Oncology
Overweight
Overweight persons
Patients
Polyclonal antibodies
serum leptin
Studies
Title Increased serum leptin level in overweight patients with colon carcinoma: A cross-sectional and prospective study
URI https://www.ncbi.nlm.nih.gov/pubmed/28123733
https://www.proquest.com/docview/1931677111
https://www.proquest.com/docview/1862284614
https://pubmed.ncbi.nlm.nih.gov/PMC5244862
Volume 6
WOSCitedRecordID wos000453170400013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2049-9469
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000970259
  issn: 2049-9450
  databaseCode: 7X7
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2049-9469
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000970259
  issn: 2049-9450
  databaseCode: BENPR
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdgQ4IXPsRXxqiMhOCFaIk_Y15QmTbxAGVCIPUtSmxHVGqTbWn39-_OdcMyCV5QpbaSL4ndO9_97J5_R8hb41zmBBepYsalQjuVFg5s2XPumM2dZS6QuH7Vs1kxn5uzuOHWx7TKnU8Mjtp1FvfIjwBo5EprmJqfzi9SrBqF_67GEhp3yT6WzUY71_MhnAKSMVzE5UTwzEZDiEdEzAAYp0bIbEu7CVGbHa0sHgbMFabd6VGYuu2sb0Sr25mU98EPtG7huv5GmDp99L8DfEweRoBKp1uLekLu-PYpuQA3gtnr3lEw2c2KLjEZpoWPK7-k8KUL-dW40KeRqbWnuMVLkRS7pRYrFrXdqvpIpzSMOO1DDhg-CkZCoa-7M580MN4-I79OT34ef0ljsYbUCsHWKTcKNCu1L3zjtHGF8lZJVtUSOd1kkVWqqWrhZG0Va1TVFI213GayEQ2rrOHPyV7btf4loYXU1rCM11xJUee6rpAo0flcNKLKmzohH3a6KW1kMseCGssSVjSoyhJUWaIqkf5UJ-TdIH6-pfD4m-B7VHSJUxvuZ6t4QgF6hSRZ5VRoowAOSZaQw5EkTEk7bt6puIwuoS__6Dchb4ZmvBLT3FrfbUAG1peAFwAyJeTF1rKGLjOAYlxznhA9srlBAInCxy3t4ncgDJfQK7hzQiaDdQ5XfTv-nmbwwh_g4N_9fkUeMAQ1YQPqkOytLzf-Nblnr9aL_nISpl54LyZk__PJ7OzHNfCZObI
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF5VBalceIiXoZRF4nHBqr1PGwmhqFC1aho4FCk3Y--uRaTEbuukiD_Fb2Rm_aCpBLceUA6JtGt7s_lm5tvN7DeEvEytjazgIlQstaHQVoWJBSw7zi0zsTXMehHXsZ5Mkuk0_bJBfvVnYTCtsveJ3lHb2uAe-S4QjVhpDab54fQsxKpR-O9qX0KjhcWR-_kDlmzN-8OP8Pu-Ymz_08neQdhVFQiNEGwZ8lTBEKR2iSutTm2inFGS5YVE8TGZRLkq80JYWRjFSpWXSWkMN5EsRclyg-JL4PJvgB_XWDFBT4fwDcwp5aJbvvhIkGqgFMjAGRDxMBUyamU-gSWw3YXBw4exwjQ_vRYWrwaHS9HxaubmFvidys5s3VwKi_t3_rcJvUtudwScjlqLuUc2XHWfnIGbxOx8ZymY5GpB55jsU8HbhZtT-FD7_HHcyKCdEm1DcQubouh3RQ1WZKrqRf6Ojqif4bDxOW74KJg5CnPTn2mlXtH3Afl6Ld_yIdms6so9JjSR2qQs4gVXUhSxLnIUgrQuFqXI47IIyNseC5nplNqxYMg8gxUbQicD6GQIHZR31QF5PXQ_bSVK_tbxDQIrQ9cF9zN5dwIDRoUiYNlI6FQB3ZMsINtrPcHlmPXmHlJZ5_Ka7A-eAvJiaMYrMY2vcvUK-sD6GfgQUMKAPGqRPAyZAdXkmvOA6DWMDx1QCH29pZp994LoEkYFdw7IzmANw1XHe5_DCF44AU_-Pe7nZOvg5HicjQ8nR0_JLYYEzm-2bZPN5fnKPSM3zcVy1pzveLOn5Nt1m8VvL1WW0A
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB5VBQEXHuJlKGWReFywaq_3YSMhFLVEVC2hB5Byc-3dtYiU2G2dFPHX-HXM-EVTCW49oBwSadf2ZvLNzLeb2W8BXibWBlZEwlc8sb7QVvmxRSy7KLLchNZw24i4HurJJJ5Ok6MN-NXvhaGyyj4mNoHaVobWyHeQaIRKa6rCKbqyiKO98YeTU59OkKJ_WvvjNFqIHLifP3D6Vr_f38Pf-hXn449fdz_53QkDvhGCL_0oUTgcqV3sCqsTGytnlORZLkmITMZBpoosF1bmRvFCZUVcGBOZQBai4JkhISYM_9dIUpB8TE-HVI4sKolEN5VpskKikV4QG-dIyv1EyKCV_ETGwHcWhjYihopK_vRairycKC5kystVnDcxBpV2Zqv6Qooc3_mfjXsXbnfEnI1aT7oHG668D6cYPqlq31mGrrpasDkVAZX4du7mDD9UTV05LXCwTqG2ZrS0zUgMvGSGTmoqq0X2jo1YY22_bmrf6FFoRYZ26ve6skbp9wF8u5Jv-RA2y6p0j4HFUpuEB1EeKSnyUOcZCURaF4pCZGGRe_C2x0VqOgV3OkhknuJMjmCUIoxSghHJvmoPXg_dT1rpkr91fEMgSymk4f1M1u3MwFGROFg6EjpRSAMl92BrrSeGIrPe3MMr7UJhnf7Blgcvhma6ksr7SletsA_Oq5EnIVX04FGL6mHIHClohB7mgV7D-9CBBNLXW8rZ90YoXeKo8M4ebA-eMVz1efeLH-CLDPDk3-N-DjfQG9LD_cnBU7jFidc1a3BbsLk8W7lncN2cL2f12XYTARgcX7VX_AarO5-M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+serum+leptin+level+in+overweight+patients+with+colon+carcinoma%3A+A+cross-sectional+and+prospective+study&rft.jtitle=Molecular+and+clinical+oncology&rft.au=Wang%2C+Di&rft.au=Gao%2C+Lichen&rft.au=Gong%2C+Kuiyu&rft.au=Chai%2C+Qin&rft.date=2017-01-01&rft.pub=D.A.+Spandidos&rft.issn=2049-9450&rft.eissn=2049-9469&rft.volume=6&rft.issue=1&rft.spage=75&rft.epage=78&rft_id=info:doi/10.3892%2Fmco.2016.1087&rft_id=info%3Apmid%2F28123733&rft.externalDocID=PMC5244862
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2049-9450&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2049-9450&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2049-9450&client=summon